No Data
No Data
VTv Therapeutics Analyst Ratings
Express News | Cantex Pharmaceuticals Receives FDA Orphan Drug Designation for Azeliragon for the Treatment of Brain Metastasis From Breast Cancer
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER
A. G. P. Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $35
Express News | VTv Therapeutics Inc : Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $35
VTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference